{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:13:56Z","timestamp":1792142036587,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Health & welfare, Republic of Korea","award":["HI22C1465"],"award-info":[{"award-number":["HI22C1465"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Transferring high-quality embryos is crucial for in vitro fertilization success, as they lead to better clinical pregnancy and live birth outcomes. Researchers have investigated adding supplements to culture media to enhance embryo quality because culture conditions greatly affect embryo quality and development. This study assessed whether adding autologous platelet-rich plasma containing growth factors and cytokines to the culture media could produce more usable and high-grade embryos. This retrospective study analyzed 175 in vitro fertilization cycles from 123 women with poor embryo development or no usable embryos in previous cycles. 5% platelet-rich plasma solution was added to the cleavage-stage culture medium, and embryos were incubated for 48\u00a0h. Embryo development rates, stage-specific usable embryos, and high-quality embryo proportions were measured. Cytokine analysis was performed to compare the platelet-rich plasma samples from patients with high- and low-quality embryos. Adding autologous platelet-rich plasma significantly improved embryo development outcomes, with higher usable embryo rates compared to untreated groups. Platelet-rich plasma enhanced outcomes at the blastocyst stage and improved high-quality embryo rates at the morula and blastocyst stages. Both POSEIDON groups II and IV showed significantly better usable embryo ratios with platelet-rich plasma. Significant differences in cytokine expression levels were observed between platelet-rich plasma samples from patients with high- and low-quality embryo samples, with notable variations in Flt-3 ligand, interleukin-23, monocyte chemoattractant protein-3, and urokinase plasminogen activator receptor. The limitations of this study are retrospective design without a placebo control group and its small sample size. Nevertheless, our findings are valuable for patients with poor prognoses, showing improved embryo development outcomes. This offers opportunities for older patients with multiple failed in vitro fertilization attempts.<\/jats:p>","DOI":"10.1038\/s41598-025-07688-x","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T23:16:49Z","timestamp":1752794209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The use of autologous platelet-rich plasma in embryo culture to obtain high-quality embryos"],"prefix":"10.1038","volume":"15","author":[{"given":"Yeo Jin","family":"Rhee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Yeon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"7688_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5653\/cerm.2022.05407","volume":"49","author":"MK Kim","year":"2022","unstructured":"Kim, M. K., Song, H., Lyu, S. W. & Lee, W. S. Platelet-rich plasma treatment in patients with refractory thin endometrium and recurrent implantation failure: A comprehensive review. Clin. Exp. Reprod. Med. 49, 168 (2022).","journal-title":"Clin. Exp. Reprod. Med."},{"key":"7688_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/19396368.2020.1862357","volume":"67","author":"H Hajipour","year":"2021","unstructured":"Hajipour, H. et al. An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: Clinical and molecular aspects. Syst. Biol. Reprod. Med. 67, 177\u2013188 (2021).","journal-title":"Syst. Biol. Reprod. Med."},{"key":"7688_CR3","first-page":"601","volume":"25","author":"AR Ferrari","year":"2021","unstructured":"Ferrari, A. R. et al. Evaluation of the effects of platelet-rich plasma on follicular and endometrial growth: A literature review. JBRA Assist. Reprod. 25, 601 (2021).","journal-title":"JBRA Assist. Reprod."},{"key":"7688_CR4","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/humrep\/deab106","volume":"36","author":"L Atkinson","year":"2021","unstructured":"Atkinson, L., Martin, F. & Sturmey, R. G. Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon?. Hum. Reprod. 36, 1737\u20131750 (2021).","journal-title":"Hum. Reprod."},{"key":"7688_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2024.103813","volume":"49","author":"M Serdarogullari","year":"2024","unstructured":"Serdarogullari, M. et al. Revitalising female fertility: platelet-rich plasma (PRP)-hype or hope?. Reprod. Biomed. Online 49, 103813 (2024).","journal-title":"Reprod. Biomed. Online"},{"key":"7688_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/humupd\/dmu040","volume":"21","author":"E Chronopoulou","year":"2015","unstructured":"Chronopoulou, E. & Harper, J. C. IVF culture media: Past, present and future. Hum. Reprod. Update 21, 39\u201355 (2015).","journal-title":"Hum. Reprod. Update"},{"key":"7688_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1017\/S0967199422000284","volume":"30","author":"MS Albal","year":"2022","unstructured":"Albal, M. S. et al. Supplementation of porcine in vitro maturation medium with FGF2, LIF, and IGF1 enhances cytoplasmic maturation in prepubertal gilts oocytes and improves embryo quality. Zygote 30, 801\u2013808 (2022).","journal-title":"Zygote"},{"key":"7688_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/genes13050805","volume":"13","author":"S Yang","year":"2022","unstructured":"Yang, S. et al. Supplementation of EGF, IGF-1, and connexin 37 in IVM medium significantly improved the maturation of bovine oocytes and vitrification of their IVF blastocysts. Genes 13, 805 (2022).","journal-title":"Genes"},{"key":"7688_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12522-015-0220-x","volume":"15","author":"H Pazoki","year":"2016","unstructured":"Pazoki, H., Eimani, H., Farokhi, F., Shahverdi, A.-H. & Tahaei, L. S. The effects of platelet lysate on maturation, fertilization and embryo development of NMRI mouse oocytes at germinal vesicle stage. Reprod. Med. Biol. 15, 115\u2013120 (2016).","journal-title":"Reprod. Med. Biol."},{"key":"7688_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/ahe.13112","volume":"53","author":"S Alaee","year":"2024","unstructured":"Alaee, S. et al. PRP influences maturation and fertilisation of immature mouse oocytes. Anat. Histol. Embryol. 53, e13112 (2024).","journal-title":"Anat. Histol. Embryol."},{"key":"7688_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.rbmo.2017.04.007","volume":"35","author":"L Hosseini","year":"2017","unstructured":"Hosseini, L. et al. Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage. Reprod. Biomed. Online 35, 343\u2013350 (2017).","journal-title":"Reprod. Biomed. Online"},{"key":"7688_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3389\/fendo.2019.00814","volume":"10","author":"SC Esteves","year":"2019","unstructured":"Esteves, S. C. et al. The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists. Front. Endocrinol. (Lausanne) 10, 814 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"7688_CR13","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3390\/cells11091549","volume":"11","author":"MK Kim","year":"2022","unstructured":"Kim, M. K. et al. Human platelet-rich plasma facilitates angiogenesis to restore impaired uterine environments with Asherman\u2019s syndrome for embryo implantation and following pregnancy in mice. Cells 11, 1549 (2022).","journal-title":"Cells"},{"key":"7688_CR14","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s43032-020-00349-6","volume":"28","author":"HJ Kim","year":"2021","unstructured":"Kim, H. J. et al. Embryo selection based on morphological parameters in a single vitrified-warmed blastocyst transfer cycle. Reprod. Sci. 28, 1060\u20131068 (2021).","journal-title":"Reprod. Sci."},{"key":"7688_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.rbmo.2011.02.001","volume":"22","author":"B Balaban","year":"2011","unstructured":"Balaban, B. et al. Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Reprod. Biomed. Online 22, 632\u2013646 (2011).","journal-title":"Reprod. Biomed. Online"},{"key":"7688_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10815-017-1063-7","volume":"35","author":"A Sallem","year":"2018","unstructured":"Sallem, A. et al. Extended culture of poor-quality supernumerary embryos improves ART outcomes. J. Assist. Reprod. Genet. 35, 311\u2013319 (2018).","journal-title":"J. Assist. Reprod. Genet."},{"key":"7688_CR17","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1111\/jog.13763","volume":"44","author":"MK Kim","year":"2018","unstructured":"Kim, M. K. et al. Effects and pregnancy outcomes of L-carnitine supplementation in culture media for human embryo development from in vitro fertilization. J. Obstet. Gynaecol. Res. 44, 2059\u20132066 (2018).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"7688_CR18","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1007\/s00404-024-07461-x","volume":"309","author":"JK Park","year":"2024","unstructured":"Park, J. K. et al. Time-lapse imaging of morula compaction for selecting high-quality blastocysts: A retrospective cohort study. Arch. Gynecol. Obstet. 309, 2897\u20132906 (2024).","journal-title":"Arch. Gynecol. Obstet."},{"key":"7688_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/humrep\/deaf097.107","volume":"40","author":"G Coticchio","year":"2025","unstructured":"Coticchio, G. et al. The Istanbul consensus update: a revised ESHRE\/ALPHA consensus on oocyte and embryo static and dynamic morphological assessment. Hum. Reprod. 40, 989\u20131035 (2025).","journal-title":"Hum. Reprod."},{"key":"7688_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/ten.teb.2019.0292","volume":"26","author":"J Fang","year":"2020","unstructured":"Fang, J. et al. Platelet-rich plasma therapy in the treatment of diseases associated with orthopedic injuries. Tissue Eng. Part B Rev. 26, 571\u2013585 (2020).","journal-title":"Tissue Eng. Part B Rev."},{"key":"7688_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cytogfr.2021.11.003","volume":"64","author":"E Cecerska-Hery\u0107","year":"2022","unstructured":"Cecerska-Hery\u0107, E. et al. Applications of the regenerative capacity of platelets in modern medicine. Cytokine Growth Factor Rev. 64, 84\u201394 (2022).","journal-title":"Cytokine Growth Factor Rev."},{"key":"7688_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/14712598.2021.1945030","volume":"22","author":"E Anitua","year":"2022","unstructured":"Anitua, E. et al. Progress in the use of plasma rich in growth factors in ophthalmology: From ocular surface to ocular fundus. Expert Opin. Biol. Ther. 22, 31\u201345 (2022).","journal-title":"Expert Opin. Biol. Ther."},{"key":"7688_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cryobiol.2021.01.009","volume":"98","author":"B Yan","year":"2021","unstructured":"Yan, B., Zhang, Y., Tian, S., Hu, R. & Wu, B. Effect of autologous platelet-rich plasma on human sperm quality during cryopreservation. Cryobiology 98, 12\u201316 (2021).","journal-title":"Cryobiology"},{"key":"7688_CR24","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10815-018-1159-8","volume":"35","author":"A Bos-Mikich","year":"2018","unstructured":"Bos-Mikich, A., de Oliveira, R. & Frantz, N. Platelet-rich plasma therapy and reproductive medicine. J. Assist. Reprod. Genet. 35, 753\u2013756 (2018).","journal-title":"J. Assist. Reprod. Genet."},{"key":"7688_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10815-021-02146-9","volume":"38","author":"FI Sharara","year":"2021","unstructured":"Sharara, F. I., Lelea, L.-L., Rahman, S., Klebanoff, J. S. & Moawad, G. N. A narrative review of platelet-rich plasma (PRP) in reproductive medicine. J. Assist. Reprod. Genet. 38, 1003\u20131012 (2021).","journal-title":"J. Assist. Reprod. Genet."},{"key":"7688_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/08977194.2021.1900168","volume":"38","author":"F Moulavi","year":"2020","unstructured":"Moulavi, F., Akram, R., Khorshid Sokhangouy, S. & Hosseini, S. Platelet rich plasma efficiently substitutes the beneficial effects of serum during in vitro oocyte maturation and helps maintain the mitochondrial activity of maturing oocytes. Growth Factors 38, 152\u2013166 (2020).","journal-title":"Growth Factors"},{"key":"7688_CR27","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jcyt.2019.04.053","volume":"21","author":"S Viau","year":"2019","unstructured":"Viau, S. et al. A highly standardized and characterized human platelet lysate for efficient and reproducible expansion of human bone marrow mesenchymal stromal cells. Cytotherapy 21, 738\u2013754 (2019).","journal-title":"Cytotherapy"},{"key":"7688_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-016-0352-x","volume":"7","author":"G Astori","year":"2016","unstructured":"Astori, G. et al. Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem\/stromal cells: present and future. Stem Cell Res. Ther. 7, 1\u20138 (2016).","journal-title":"Stem Cell Res. Ther."},{"key":"7688_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.mefs.2015.01.006","volume":"20","author":"H Pazoki","year":"2015","unstructured":"Pazoki, H. et al. Comparing the growth and the development of mouse pre-antral follicle in medium with PL (Platelet Layset) and with FBS. Middle East Fertil. Soc. J. 20, 231\u2013236 (2015).","journal-title":"Middle East Fertil. Soc. J."},{"key":"7688_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2023.06.011","volume":"47","author":"CS Adrados","year":"2023","unstructured":"Adrados, C. S. et al. Human platelet lysate improves the growth and survival of cultured human pre-antral follicles. Reprod. Biomed. Online 47, 103256 (2023).","journal-title":"Reprod. Biomed. Online"},{"key":"7688_CR31","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1007\/s11250-020-02307-5","volume":"52","author":"P Ramos-Deus","year":"2020","unstructured":"Ramos-Deus, P. et al. Application of platelet-rich plasma in the in vitro production of bovine embryos. Trop. Anim. Health Prod. 52, 2931\u20132936 (2020).","journal-title":"Trop. Anim. Health Prod."},{"key":"7688_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrm2821","volume":"11","author":"HW Smith","year":"2010","unstructured":"Smith, H. W. & Marshall, C. J. Regulation of cell signalling by uPAR. Nat. Rev. Mol. Cell Biol. 11, 23\u201336 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"7688_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s429-001-8004-7","volume":"204","author":"EJ Whiteside","year":"2001","unstructured":"Whiteside, E. J. et al. Urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) expression and activity during early embryo development in the cow. Anat. Embryol. 204, 477\u2013483 (2001).","journal-title":"Anat. Embryol."},{"key":"7688_CR34","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0015-0282(03)00782-9","volume":"80","author":"H Wang","year":"2003","unstructured":"Wang, H. et al. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human preimplantation embryos. Fertil. Steril. 80, 736\u2013742 (2003).","journal-title":"Fertil. Steril."},{"key":"7688_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1530\/REP-16-0517","volume":"153","author":"A Highet","year":"2017","unstructured":"Highet, A. et al. A novel embryo culture media supplement that improves pregnancy rates in mice. Reproduction 153, 327\u2013340 (2017).","journal-title":"Reproduction"},{"key":"7688_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/molehr\/2.4.273","volume":"2","author":"F Khamsi","year":"1996","unstructured":"Khamsi, F., Armstrong, D. & Zhang, X. Premplantation embryology. Mol. Hum. Reprod. 2, 273\u2013276 (1996).","journal-title":"Mol. Hum. Reprod."},{"key":"7688_CR37","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","volume":"100","author":"DG Gilliland","year":"2002","unstructured":"Gilliland, D. G. & Griffin, J. D. The roles of FLT3 in hematopoiesis and leukemia. Blood 100, 1532\u20131542 (2002).","journal-title":"Blood"},{"key":"7688_CR38","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1182\/blood.V91.4.1101","volume":"91","author":"SD Lyman","year":"1998","unstructured":"Lyman, S. D. & Jacobsen, S. E. W. c-kit ligand and Flt3 ligand: stem\/progenitor cell factors with overlapping yet distinct activities. Blood 91, 1101\u20131134 (1998).","journal-title":"Blood"},{"key":"7688_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1274\/jmor.31.45","volume":"31","author":"C Nishijima","year":"2014","unstructured":"Nishijima, C. et al. Regulation of preimplantation embryo development in mice by FMS-like tyrosine kinase 3 ligand. J. Mamm. Ova. Res. 31, 45\u201351 (2014).","journal-title":"J. Mamm. Ova. Res."},{"key":"7688_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-0897.2004.00176.x","volume":"52","author":"J Nautiyal","year":"2004","unstructured":"Nautiyal, J., Kumar, P. G. & Laloraya, M. Mifepristone (Ru486) antagonizes monocyte chemotactic protein-3 down-regulation at early mouse pregnancy revealing immunomodulatory events in Ru486 induced abortion. Am. J. Reprod. Immunol. 52, 8\u201318 (2004).","journal-title":"Am. J. Reprod. Immunol."},{"key":"7688_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163252","volume":"11","author":"J Cai","year":"2016","unstructured":"Cai, J., Li, M., Huang, Q., Fu, X. & Wu, H. Differences in cytokine expression and STAT3 activation between healthy controls and patients of unexplained recurrent spontaneous abortion (URSA) during early pregnancy. PLoS ONE 11, e0163252 (2016).","journal-title":"PLoS ONE"},{"key":"7688_CR42","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.3390\/ijms25074006","volume":"25","author":"T-C Tsai","year":"2024","unstructured":"Tsai, T.-C. et al. Detection of interleukin-1 \u03b2 (IL-1\u03b2) in single human blastocyst-conditioned medium using ultrasensitive bead-based digital microfluidic chip and its relationship with embryonic implantation potential. Int. J. Mol. Sci. 25, 4006 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"7688_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0165-0378(97)00030-2","volume":"34","author":"J Kruessel","year":"1997","unstructured":"Kruessel, J. et al. Different pattern of interleukin-1\u03b2-(IL-1\u03b2), interleukin-1 receptor antagonist-(IL-1ra) and interleukin-1 receptor type I-(IL-1R tI) mRNA-expression in single preimplantation mouse embryos at various developmental stages. J. Reprod. Immunol. 34, 103\u2013120 (1997).","journal-title":"J. Reprod. Immunol."},{"key":"7688_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1530\/REP-20-0376","volume":"161","author":"M Pathak","year":"2021","unstructured":"Pathak, M., Vani, V., Sharma, S. & Seshagiri, P. B. Expression of IL-1\u03b2 and implantation serine proteases is required for mouse blastocyst hatching. Reproduction 161, 123\u2013133 (2021).","journal-title":"Reproduction"},{"key":"7688_CR45","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/jcb.29345","volume":"121","author":"Y Pan","year":"2020","unstructured":"Pan, Y. et al. Interleukin-1 beta induces autophagy of mouse preimplantation embryos and improves blastocyst quality. J. Cell. Biochem. 121, 1087\u20131100 (2020).","journal-title":"J. Cell. Biochem."},{"key":"7688_CR46","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3390\/ijms23042198","volume":"23","author":"K Pantos","year":"2022","unstructured":"Pantos, K. et al. The role of interleukins in recurrent implantation failure: A comprehensive review of the literature. Int. J. Mol. Sci. 23, 2198 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"7688_CR47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jri.2017.12.003","volume":"125","author":"SA Robertson","year":"2018","unstructured":"Robertson, S. A., Chin, P.-Y., Femia, J. G. & Brown, H. M. Embryotoxic cytokines\u2014potential roles in embryo loss and fetal programming. J. Reprod. Immunol. 125, 80\u201388 (2018).","journal-title":"J. Reprod. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07688-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07688-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07688-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:34:30Z","timestamp":1757259270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07688-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7688"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07688-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics committee of the Institutional Review Board of CHA Gangnam Medical Center (IRB approval no. GCI 2023-02-006). Given the retrospective design of the study and its reliance on medical records, the need for obtaining participant consent was waived by the approval committee. However, the study was conducted in strict adherence to relevant privacy regulations and guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"26025"}}